S&P 500   5,122.62 (-1.47%)
DOW   37,963.40 (-1.29%)
QQQ   438.14 (-1.62%)
AAPL   175.91 (+0.50%)
MSFT   421.60 (-1.48%)
META   512.09 (-2.12%)
GOOGL   157.53 (-1.18%)
AMZN   185.77 (-1.73%)
TSLA   171.62 (-1.71%)
NVDA   884.92 (-2.34%)
AMD   163.17 (-4.30%)
NIO   4.15 (-6.95%)
BABA   71.93 (-3.90%)
T   16.34 (-0.49%)
F   12.59 (-3.45%)
MU   122.65 (-3.81%)
GE   154.92 (-1.58%)
CGC   7.79 (-4.42%)
DIS   114.36 (-2.38%)
AMC   2.66 (-5.00%)
PFE   26.00 (-1.29%)
PYPL   64.41 (-2.11%)
XOM   121.17 (-0.51%)
S&P 500   5,122.62 (-1.47%)
DOW   37,963.40 (-1.29%)
QQQ   438.14 (-1.62%)
AAPL   175.91 (+0.50%)
MSFT   421.60 (-1.48%)
META   512.09 (-2.12%)
GOOGL   157.53 (-1.18%)
AMZN   185.77 (-1.73%)
TSLA   171.62 (-1.71%)
NVDA   884.92 (-2.34%)
AMD   163.17 (-4.30%)
NIO   4.15 (-6.95%)
BABA   71.93 (-3.90%)
T   16.34 (-0.49%)
F   12.59 (-3.45%)
MU   122.65 (-3.81%)
GE   154.92 (-1.58%)
CGC   7.79 (-4.42%)
DIS   114.36 (-2.38%)
AMC   2.66 (-5.00%)
PFE   26.00 (-1.29%)
PYPL   64.41 (-2.11%)
XOM   121.17 (-0.51%)
S&P 500   5,122.62 (-1.47%)
DOW   37,963.40 (-1.29%)
QQQ   438.14 (-1.62%)
AAPL   175.91 (+0.50%)
MSFT   421.60 (-1.48%)
META   512.09 (-2.12%)
GOOGL   157.53 (-1.18%)
AMZN   185.77 (-1.73%)
TSLA   171.62 (-1.71%)
NVDA   884.92 (-2.34%)
AMD   163.17 (-4.30%)
NIO   4.15 (-6.95%)
BABA   71.93 (-3.90%)
T   16.34 (-0.49%)
F   12.59 (-3.45%)
MU   122.65 (-3.81%)
GE   154.92 (-1.58%)
CGC   7.79 (-4.42%)
DIS   114.36 (-2.38%)
AMC   2.66 (-5.00%)
PFE   26.00 (-1.29%)
PYPL   64.41 (-2.11%)
XOM   121.17 (-0.51%)
S&P 500   5,122.62 (-1.47%)
DOW   37,963.40 (-1.29%)
QQQ   438.14 (-1.62%)
AAPL   175.91 (+0.50%)
MSFT   421.60 (-1.48%)
META   512.09 (-2.12%)
GOOGL   157.53 (-1.18%)
AMZN   185.77 (-1.73%)
TSLA   171.62 (-1.71%)
NVDA   884.92 (-2.34%)
AMD   163.17 (-4.30%)
NIO   4.15 (-6.95%)
BABA   71.93 (-3.90%)
T   16.34 (-0.49%)
F   12.59 (-3.45%)
MU   122.65 (-3.81%)
GE   154.92 (-1.58%)
CGC   7.79 (-4.42%)
DIS   114.36 (-2.38%)
AMC   2.66 (-5.00%)
PFE   26.00 (-1.29%)
PYPL   64.41 (-2.11%)
XOM   121.17 (-0.51%)

Corbus Pharmaceuticals (CRBP) Short Interest Ratio & Short Volume

$39.84
-0.16 (-0.40%)
(As of 02:09 PM ET)

Corbus Pharmaceuticals Short Interest Data

Current Short Volume
475,600 shares
Previous Short Volume
403,800 shares
Change Vs. Previous Month
+17.78%
Dollar Volume Sold Short
$18.66 million
Short Interest Ratio / Days to Cover
0.5
Last Record Date
March 31, 2024
Outstanding Shares
10,510,000 shares
Float Size
10,380,000 shares
Short Percent of Float
4.58%
Today's Trading Volume
128,958 shares
Average Trading Volume
841,365 shares
Today's Volume Vs. Average
15%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Corbus Pharmaceuticals ?

Sign up to receive the latest short interest report for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRBP Short Interest Over Time

CRBP Days to Cover Over Time

CRBP Percentage of Float Shorted Over Time

Corbus Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024475,600 shares $18.66 million +17.8%4.6%0.5 $39.24
3/15/2024403,800 shares $17.64 million +560.9%3.9%0.5 $43.68
2/29/202461,100 shares $1.89 million -34.2%0.6%0.1 $30.90
2/15/202492,900 shares $2.09 million -80.0%0.9%0.1 $22.48
1/31/2024464,700 shares $12.31 million +1,553.7%4.5%0.6 $26.49
1/15/202428,100 shares $166,633.00 -29.4%0.6%1.2 $5.93
12/31/202339,800 shares $240,392.00 -16.4%0.9%2.2 $6.04
12/15/202347,600 shares $261,800.00 +4.6%1.1%3.1 $5.50
11/30/202345,500 shares $304,395.00 -19.8%1.0%3.4 $6.69
11/15/202356,700 shares $255,717.00 +3.3%1.3%4.7 $4.51
10/31/202354,900 shares $299,205.00 -11.0%1.2%5.1 $5.45
10/15/202361,700 shares $372,051.00 -3.1%1.4%6.4 $6.03
9/30/202363,700 shares $429,338.00 -2.6%1.4%5.7 $6.74
9/15/202365,400 shares $459,108.00 -13.3%1.5%5.4 $7.02
8/31/202375,400 shares $550,420.00 -6.1%1.7%5.2 $7.30
8/15/202380,300 shares $514,723.00 -10.6%1.8%4.5 $6.41
7/31/202389,800 shares $646,560.00 -8.6%2.0%3.8 $7.20
7/15/202398,200 shares $753,194.00 -13.3%2.2%2.7 $7.67
6/30/2023113,300 shares $888,272.00 +0.2%2.6%2 $7.84
6/15/2023113,100 shares $876,525.00 +4.9%2.6%1.3 $7.75
5/31/2023107,800 shares $1.02 million -23.6%2.6%0.2 $9.47
5/15/2023141,100 shares $1.48 million -31.2%3.4%0.3 $10.50
4/30/2023205,100 shares $1.80 million -31.0%4.9%0.5 $8.78
4/15/2023297,200 shares $2.85 million -17.7%7.2%0.7 $9.59
3/31/2023360,900 shares $2.62 million +147.0%8.7%0.8 $7.27
3/15/2023146,100 shares $425,151.00 -1.8%3.5%0.4 $2.91
2/28/2023148,700 shares $444,613.00 +25.1%3.6%2 $2.99
2/15/2023118,900 shares $366,212.00 -96.0%2.9%0.8 $3.08
1/31/20232,960,000 shares $459,096.00 -5.4%2.4%0.7 $0.16
1/15/20233,130,000 shares $453,224.00 -15.0%2.5%0.7 $0.14
12/30/20223,680,000 shares $406,640.00 -20.7%3.0%0.7 $0.11
12/15/20224,640,000 shares $575,360.00 +17.8%3.7%0.9 $0.12
11/30/20223,940,000 shares $766,330.00 -15.1%3.2%0.8 $0.19
11/15/20224,640,000 shares $625,472.00 -2.5%3.7%1.9 $0.13
10/31/20224,760,000 shares $618,800.00 +22.1%3.8%1.9 $0.13
10/15/20223,900,000 shares $468,000.00 +4.8%3.1%1.6 $0.12
9/30/20223,720,000 shares $613,800.00 +10.7%3.0%3.6 $0.17
9/15/20223,360,000 shares $697,536.00 -11.6%2.7%3.6 $0.21
8/31/20223,800,000 shares $766,080.00 -1.6%3.1%4.5 $0.20
8/15/20223,860,000 shares $992,406.00 +18.4%3.1%4.4 $0.26
Gold Hits New All-Time Highs (Ad)

Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!

Read Colonial Metals' new Precious Metals Investment Guide.

CRBP Short Interest - Frequently Asked Questions

What is Corbus Pharmaceuticals' current short interest?

Short interest is the volume of Corbus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 475,600 shares of CRBP short. 4.58% of Corbus Pharmaceuticals' shares are currently sold short. Learn More on Corbus Pharmaceuticals' current short interest.

Which institutional investors are shorting Corbus Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corbus Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Corbus Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.58% of Corbus Pharmaceuticals' floating shares are currently sold short.

Is Corbus Pharmaceuticals' short interest increasing or decreasing?

Corbus Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 475,600 shares, an increase of 17.8% from the previous total of 403,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Corbus Pharmaceuticals' float size?

Corbus Pharmaceuticals currently has issued a total of 10,510,000 shares. Some of Corbus Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corbus Pharmaceuticals currently has a public float of 10,380,000 shares.

How does Corbus Pharmaceuticals' short interest compare to its competitors?

4.58% of Corbus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Corbus Pharmaceuticals: ADC Therapeutics SA (1.81%), PepGen Inc. (1.48%), Mereo BioPharma Group plc (1.86%), Atai Life Sciences (4.81%), Adlai Nortye Ltd. (0.02%), Organogenesis Holdings Inc. (9.35%), Neoleukin Therapeutics, Inc. (0.35%), Heron Therapeutics, Inc. (17.00%), Shattuck Labs, Inc. (4.40%), Terns Pharmaceuticals, Inc. (10.92%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Corbus Pharmaceuticals stock?

Short selling CRBP is an investing strategy that aims to generate trading profit from Corbus Pharmaceuticals as its price is falling. CRBP shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Corbus Pharmaceuticals?

A short squeeze for Corbus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBP, which in turn drives the price of the stock up even further.

How often is Corbus Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBP, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CRBP) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners